Scancell Holdings is Biotechnology in United Kingdom that focus on ImmunoBody therapies business. Founded in 1997. They cover business area such as Scancell Holdings PLC, development, novel vaccine, cancer, two proprietary immuno-oncology platform, ImmunoBody, Moditope, tumor.
1997
( 27 years old in 2024 )
ImmunoBody Therapies
-
John Eccles House
Robert Robinson Avenue, Oxford Science Park
Oxford OX4 4GP
England, United Kingdom
Private
Scancell Holdings PLCdevelopmentnovel vaccinecancertwo proprietary immuno-oncology platformImmunoBodyModitopetumor
* We use standard office opening hours in near Scancell Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Scancell Holdings is Biotechnology business from United Kingdom that founded in 1997 (27 years old in 2024), Scancell Holdings business is focusing on ImmunoBody Therapies.
Scancell Holdings headquarter office and corporate office address is located in John Eccles House Robert Robinson Avenue, Oxford Science Park Oxford OX4 4GP England, United Kingdom.
Scancell Holdings was founded in United Kingdom.
In 2024, Scancell Holdings is currently focus on ImmunoBody therapies sector.
Above is snippet of Google Trends for "ImmunoBody therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Scancell Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
